Previous studies revealed a latitudinal gradient of multiple sclerosis (MS) prevalence,
increasing by moving from the equator to the poles. The duration and quality of an …

The identification of protective agents for the treatment of neurodegenerative diseases is the
mainstay therapeutic goal to modify the disease course and arrest the irreversible disability …

Conflicting results on melatonin synthesis in multiple sclerosis (MS) have been reported due
to variabilities in patient lifestyles, which are not considered when supplementing melatonin …

Background Through the antioxidant and anti-inflammation pathways, melatonin is
proposed as a safe and effective intervention in neurological diseases. This study aims to …

Several studies have proposed a potential role for oxidative stress in the development of
multiple sclerosis (MS). For this reason, it seems tentative to think that treatment with …

Neurodegenerative diseases are a serious health issue globally. High morbidity and
mortality of these disorders lead to researchers further exploring more effective preventive …

Background Decreased endogenous melatonin concentrations in people with multiple
sclerosis (PwMS) are associated with fatigue and pain that impair postural balance and …

Effects of melatonin on the management of multiple sclerosis: A scoping review on animal
studies Page 1 AIMS Medical Science, 11(2): 137–156. DOI: 10.3934/medsci.2024012 …

Different endogenous and exogenous factors are involved in multiple sclerosis (MS)
pathogenesis, an autoimmune disease. However, conflicting results are reported concerning …